Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro

Immunobiology

Volumn 217, Issue 8, 2012, Pages 788-794

  Verdan, F F ^a   Faleiros, J C ^a   Ferreira, L S ^a   Monnazzi, L G S ^a   Maia, D C G ^a   Tansine, A ^a   Placeres, M C P ^a   Carlos, I Z ^a   Santos Junior, R R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

DCs; Exoantigen; Immunomodulation; S. schenckii; T cell

Indexed keywords

FUNGUS ANTIGEN; INTERLEUKIN 23; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS; SURVIVAL RATE; T LYMPHOCYTE; TH1 CELL; TH17 CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD11C; ANTIGENS, FUNGAL; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-23; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; SPOROTHRIX; SPOROTRICHOSIS; TH1 CELLS; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84862489306     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.04.006     Document Type: Article

References (39)

1. Aarestrup F.M., Guerra R.O., et al. Oral manifestation of sporotrichosis in AIDS patients. Oral Dis. 2001, 7(2):134-136.
2. Bacci A., Montagnoli C., et al. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J. Immunol. 2002, 168(6):2904-2913.
3. Banchereau J., Briere F., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
4. Barros M.B., Schubach Ade O., et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin. Infect. Dis. 2004, 38(4):529-535.
5. Bettelli E., Korn T., et al. Induction and effector functions of T(H)17 cells. Nature 2008, 453(7198):1051-1057.
6. Bozza S., Perruccio K., et al. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 2003, 102(10):3807-3814.
7. Bozza S., Montagnoli C., et al. Dendritic cell-based vaccination against opportunistic fungi. Vaccine 2004, 22(7):857-864.
8. Buentke E., Scheynius A. Dendritic cells and fungi. APMIS 2003, 111(7-8):789-796.
9. Carlos I.Z., Sgarbi D.B., et al. Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathologia 1992, 117(3):139-144.
10. Carlos I.Z., Sgarbi D.B., et al. Host organism defense by a peptide-polysaccharide extracted from the fungus Sporothrix schenckii. Mycopathologia 1999, 144(1):9-14.
11. Carlos I.Z., Sgarbi D.B., et al. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Scand. J. Immunol. 2003, 57(3):214-220.
12. Chamilos G., Ganguly D., et al. Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses. PLoS One 2010, 5(9):e12955.
13. d'Ostiani C.F., Del Sero G., et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 2000, 191(10):1661-1674.
14. Deepe G.S., Gibbons R.S. Interleukins 17 and 23 influence the host response to Histoplasma capsulatum. J. Infect. Dis. 2009, 200(1):142-151.
15. Dickerson C.L., Taylor R.L., et al. Susceptibility of congenitally athymic (nude) mice to sporotrichosis. Infect. Immun. 1983, 40(1):417-420.
16. Gildea L.A., Morris R.E., et al. Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J. Immunol. 2001, 166(2):1049-1056.
17. Gocke A.R., Cravens P.D., et al. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 2007, 178(3):1341-1348.
18. Huang W., Na L., et al. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 2004, 190(3):624-631.
19. Joffre O., Nolte M.A., et al. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 2009, 227(1):234-247.
20. Kleinschek M.A., Muller U., et al. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol. 2006, 176(2):1098-1106.
21. Korn T., Bettelli E., et al. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
22. Losman J.A., Cavanaugh K. Cases from the Osler Medical Service at Johns Hopkins University. Diagnosis: P. carinii pneumonia and primary pulmonary sporotrichosis. Am. J. Med. 2004, 117(5):353-356.
23. Lowry O.H., Rosebrough N.J., et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193(1):265-275.
24. Manel N., Unutmaz D., et al. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 2008, 9(6):641-649.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65(1-2):55-63.
26. Nascimento R.C., Almeida S.R. Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMS Immunol. Med. Microbiol. 2005, 43(2):241-247.
27. Nascimento R.C., Espindola N.M., et al. Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur. J. Immunol. 2008, 38(11):3080-3089.
28. Newman S.L., Holly A. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect. Immun. 2001, 69(11):6813-6822.
29. Rafal E.S., Rasmussen J.E. An unusual presentation of fixed cutaneous sporotrichosis: a case report and review of the literature. J. Am. Acad. Dermatol. 1991, 25(5 Pt 2):928-932.
30. Romani L. Immunity to fungal infections. Nat. Rev. Immunol. 2011, 11(4):275-288.
31. Ruiz-Baca E., Toriello C., et al. Isolation and some properties of a glycoprotein of 70kDa (Gp70) from the cell wall of Sporothrix schenckii involved in fungal adherence to dermal extracellular matrix. Med. Mycol. 2009, 47(2):185-196.
32. Scott E.N., Muchmore H.G. Immunoblot analysis of antibody responses to Sporothrix schenckii. J. Clin. Microbiol. 1989, 27(2):300-304.
33. Segal B.H. Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. Oncologist 2007, 12(Suppl. 2):7-13.
34. Serrano-Gomez D., Leal J.A., et al. DC-SIGN mediates the binding of Aspergillus fumigatus and keratinophylic fungi by human dendritic cells. Immunobiology 2005, 210(2-4):175-183.
35. Tachibana T., Matsuyama T., et al. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med. Mycol. 1999, 37(6):397-404.
36. Teixeira P.A., de Castro R.A., et al. Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii. Microbiology 2009, 155(Pt 11):3730-3738.
37. Uenotsuchi T., Takeuchi S., et al. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence. Int. Immunol. 2006, 18(12):1637-1646.
38. Wuthrich M., Gern B., et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J. Clin. Invest. 2011, 121(2):554-568.
39. Zhu J., Yamane H., et al. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 2010, 28:445-489.